Loading...

Tackling breast cancer chemoresistance with nano-formulated siRNA

Breast cancer is the leading cancer diagnosed in women and the second leading cause of cancer-related deaths in women. Current limitations to standard chemotherapy in the clinic are extensively researched, including problems arising from repeated treatments with the same drugs. The phenomenon that c...

Full description

Saved in:
Bibliographic Details
Published in:Gene Ther
Main Authors: Jones, SK, Merkel, OM
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5540231/
https://ncbi.nlm.nih.gov/pubmed/27648580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2016.67
Tags: Add Tag
No Tags, Be the first to tag this record!